 |
|
|
FORUM « Ohio AG vs. rating agencies | Wrongful death bill in Trenton » December 15, 2009"Off-Label Promotion and False Claims" Beck & Herrmann note an Eleventh Circuit case at the intersection of FDA pharmaceutical regulation and qui tam litigation. Posted by Walter Olson at 12:13 AM | TrackBack (0) |
|
|
Published by the Manhattan Institute
| ||
